VerityXR is proud to be partnering with CPNN+ to develop responsible neurotechnology for chronic pain
Photo: Douglas Nelson, PhD, VerityXR’s Chief Architect & Engineer interacting with neuroscientists at Oxford University, UK.
VerityXR is proud to be partnering with CPNN+ (Chronic Pain Neurotechnology Network+) to develop responsible neurotechnology for chronic pain.
The UKRI (United Kingdom Research & Innovation) CPNN+ is an EPSRC (Engineering & Physical Sciences Research Council)-funded community of researchers, clinicians and technologists dedicated to translational neurotechnology and innovation in the management of chronic pain.
The network oversees a diverse range of activities to support research, training and collaboration.